anonymous
Guest
anonymous
Guest
I agree... Not happening.
BUT, they could let the rest of Syneos go, end the contract completely. Then just shuffle around the GSK reps a little if needed in some districts (i.e. instead of 3 GSK in a territory, have one move to replace the Syneos rep in a nearby territory). Then they can all have Nucala too and GSK trims a little more, but doesn't have to pay out huge severances. That actually seems pretty logical to me. I know some Syneos reps that would probably be a-ok with that too. And really, why would you still have THREE gsk reps in a single territory?! Especially now when Covid is still causing limited access!
BUT, they could let the rest of Syneos go, end the contract completely. Then just shuffle around the GSK reps a little if needed in some districts (i.e. instead of 3 GSK in a territory, have one move to replace the Syneos rep in a nearby territory). Then they can all have Nucala too and GSK trims a little more, but doesn't have to pay out huge severances. That actually seems pretty logical to me. I know some Syneos reps that would probably be a-ok with that too. And really, why would you still have THREE gsk reps in a single territory?! Especially now when Covid is still causing limited access!